Bloomberg Markets The Close：Elsevier的新人工智慧工具

A Key Partner in Delivering Innovation in Healthcare: AI’s Impact on Clinical Decision Support, R&D, and Personalised Medicine

By Jan Herzhoff, PhD President, Health Markets at Elsevier The AI Journal

Healthcare innovation is moving at a faster pace than ever, with AI unlocking groundbreaking possibilities in enhancing effectiveness and time savings while conducting research, clinical decision support, administrative duties, patient interactions and personalised treatments. AI can now assist doctors in treating diseases more rapidly, discovering life-saving drugs, and tailoring treatments specifically to people’s unique genetic makeup. The global AI in healthcare market surged from £1.1 billion in 2016 to an astonishing £22.4 billion in 2023 – a remarkable 1,779% increase [Source: Dialog Health, AI in Healthcare Statistics: Comprehensive List for 2025]. This extraordinary growth illustrates the immense potential of AI to revolutionise medical practice while providing solutions to mounting challenges facing healthcare and improving patient outcomes.

However, embracing this integration with a thoughtful and measured approach is essential. We must observe, assess, and refine AI’s role in healthcare to ensure these technologies enhance, rather than disrupt, medical practice. By studying AI’s real-world impact, healthcare professionals can effectively shape its role in addressing both medical and patient needs.